- Breakthrough ambient text-to-speech technology captures and digitizes behavioral health sessions, allowing care providers to focus on therapeutic alliance and personalized care
- Overlaying any consumer EHR, Eleos autonomously identifies session themes and generates post-session clinical progress notes, providing clinicians with new insights into potential gaps in care or the need for care coordination
- Used by more than 20 providers and national health plans, Eleos seeks to unlock up to 30% more provider capacity as the United States grapples with shortages of behavioral health clinicians
BOSTON and TEL AVIVIsrael , April 5, 2022 /PRNewswire/ — Eleos Healththe leader in CareOps Automation for behavioral health, today announced that it has raised $20 million in Series A funding. The round was co-led by F-Prime Capital and Eight Roads Ventureswith the participation of existing investors aMoon Fund, lol venture outand Arkin Holdingsbringing the total increase of Eleos to $28 million.
30 million Americans live with untreated mental health issues. Even the most optimistic calculations show that the current supply of 600,000 active US licensed therapists is far from meeting patient demand. As the United States strives to expanding its behavioral health workforceexisting mental health care providers assume a overwhelming workloadwith self-declaration burnout rate among psychiatrists at 78%.
Launched in early 2020, Eleos Health is a breakthrough clinical application for voice AI, operating ambiently in the background of behavioral health clinician-patient conversations (full patient consent and authorization are prerequisites for clinical use).
Overlaying common and usable electronic health records (EHRs) in virtual and in-person care environments, Eleos securely and autonomously captures and interprets session themes and moments, generating post-session clinical progress notes and assurance coding. On average, Eleos reduces clinician documentation time by 40%. Eleos’ superpower is its ability to empower both individual clinicians and clinical management with fresh ideas. Some of the most common information produced by Eleos are:
- Recurring in-session keywords covering main topics and moments of conversation
- How a clinical intervention was used: CCT may include a mood check, agenda setting, thoughtful listening, homework, and action plan
- Clinician listening time versus talk time, or when and how often a clinician interrupts a patient
- Percentage of practice-wide clinicians providing evidence-based practice
- Patient improvement rate
“Behavioral health practitioners deserve cutting-edge technology that is representative of and equal to the role they play in providing care and healing,” said Alon Joffe, CEO and Co-Founder, Eleos Health. “In behavioral care, the conversation is the treatment. For the first time, Eleos helps digitize and manage the unstructured nature of behavioral health conversations, giving psychotherapists a new line of sight into needs, progress, and patient outcomes.”
Eleos is currently used by thousands of clinicians at more than 20 national health care providers and plans, including Gaudenzia Home, Brookline Center for Mental Health, and Coleman Health Services. Eleos has captured over 6.5 million minutes of processing to date and expects 30 million minutes captured by the end of 2022.
“When our clinicians are in session with patients, they may be listening for relational energy, body language, or empathetic mirroring in addition to patient vocal feedback and overall dialogue,” said Dr. Dale Klatzker, CEO, Gaudenzia Home. “Eleos has given our team a new level of understanding of how we deliver care and how patients respond. Smart, augmentative, non-intrusive technology like Eleos improves our team’s ability to focus on clinician-patient trust and overall treatment and outcomes.”
“Eleos Health offers a unique approach, combining the power of voice and natural language understanding, along with enterprise-grade security and compliance standards in the clinical workflow. Eleos enables providers and payers to unlock synchronization of behavioral, medical and SDoH data, leading to better outcomes and reduced clinician burnout,” said Carl Byer, Partner at F-Prime Capital. “We look forward to working with this talented team as they take the next steps to scale the business.”
“Eleos offers a unique approach that harnesses the power of voice and natural language understanding coupled with enterprise-grade security and compliance standards directly into the clinical workflow,” said Before the lever, Managing Partner, Eight Roads Ventures. “CareOps Automation is the future of behavioral health. It enables providers and payers to unlock the holy grail of behavioral health – synchronization of behavioral, medical and SDoH data to improve outcomes and reduce clinician burnout without changing the clinical workflow.”
About Eleos Health
Eleos is the pioneer of CareOps Automation. By consolidating the entire behavioral care workflow – from progress notes to session intelligence – clinicians are freed from time-consuming operational burdens. Eleos takes care of CareOps, focusing on automating operational necessities including all documentation, compliance administration, as well as providing deep clinical insights through session intelligence. Eleos makes evidence-based behavioral care a reality so clinicians, providers, and networks can measurably and comparatively track treatment and progress. Now, clinicians focus entirely on the care itself. Thus, the care they aim to provide becomes the care they actually provide. Eleos. More care. Fewer operations.
About F-Prime Capital
F-Prime Capital is a global venture capital firm investing in healthcare and technology. Over the past 50 years, our venture capital group has had the privilege of supporting great entrepreneurs in the creation of forward-thinking companies. With over $3 billion under management and a global portfolio of more than 200 companies, we champion those dedicated to creating positive change in the world. Our healthcare fund has created or co-founded 27 companies, including Denali, Beam, Innovent, Orchard and Sana, and has helped create many more, including Blueprint Medicines, Iora Health, PatientPing, Devoted and Ultragenyx. F-Prime portfolio companies have seen more than 30 products and drugs approved by regulatory bodies around the world. Our team of investors, engineers, doctors and scientists are committed to bringing the insight, domain expertise and connections needed to help our companies achieve transformational impact.
For more information, please visit www.fprimecapital.com.
About eight roads
Eight Roads is a global venture capital firm managing over $6 billion assets in offices in the United Kingdom, China, India and Japan. It supports and partners with game-changing technology and healthcare companies and its 50 years of investing includes partnerships with over 300 companies including Alibaba, AppsFlyer, Cazoo, Fireblocks, Funnel.io, Gloat, Hibob, Icertis, Made.com, Neo4j, Spendesk, Paidy, Ping Identity, Pony.ai, Wallapop and WuXi PharmaTech. For more information, please visit eightroutes.com.
Nate Hermes | 646-828-9172
Loretta Mock | 646-726-7886
SOURCE Eleos Health